본문으로 이동

EUDIPIA Inc. EUDIPIA Inc.


An expert in the diagnostic industry focusing on the molecular diagnosisEudipia Inc.

History

Philosophy

In the today’s modern world the greatest issues to all of us worldwide are aging society and increase of medical costs. To resolve these issues professionals of related fields are diligently searching for solutions in multifaceted ways. We think that one of the solutions is the diagnostic technique in a bio convergence technologies. An accurate diagnosis results greatly in decrease in the medical expense by reducing the treatment cost and the hospitalization.

Eudipia Inc. is an expert in the diagnostic industry focusing on the molecular diagnosis. The diagnosis of tuberculosis is a beginning of our journey to develop more diagnostic products for various diseases. Tuberculosis is still one of dangerous diseases putting human in danger. Eudipia Inc. was established with a goal of being the No. 1 in Tuberculosis diagnosis. Then we are going to expand our specialties to the diagnosis of respiratory diseases and to the early diagnosis of various cancers. Eudipia was named with a vision of making a Utopia for diagnosis. With this vision in mind I will move forward to make the world best company in diagnosis.

History

  • 2018
    Nov
    Certified CE for EuDX™–PN MLC
    Sept
    Participated Thailand Lab
    July
    Participated AACC, US
    June
    GMP certified
    May
    Mission to East Europe
    March
    Participated in KIMES 2018, Seoul, Korea
    Feb
    Participated in MEDLAB 2018, Dubai, UAE
  • 2017
    Sep
    Acquired approval for EuDxTM- PN detection kit from KFDA
    Aug
    Participated in CMEH 2017, China
    Aug
    Comarketing with “W” in Phillipine Executed Sales Contract for EuDxTM - PN detection
    May
    Certified CE for EuDXTM–MTB
    May
    Participated in CMEF Spring 2017, Shanghai, China
    April
    Participated BioKorea 2017
    Jan
    2017 Korea Trade Mission to South East Asia
  • 2016
    Nov
    Participated in CMEF Autumn2016, Shenzhen, China
    Sep
    Executed MOU with Kimia Salamat Nikan, Iran
    Aug
    EuDx ™ trademark registration application in China
    Jun
    Exclusive Agency& Representation Agreement with Sonifar, Turkey
    May
    Joint research agreement with RITM(Research Institute for Tropical Medicine-Department of Health), Philippines
    April
    Participated Korea-UK Startup Forum(Brightstar) 2016
    Mar
    Participated BioKorea2016
  • 2015
    Dec
    Executed MOU with Willore, The Philippines
    Dec
    Participated the Korea-Vietnam FTA Show in Hanoi
    Sep
    2015 Korea Trade Mission to South East Asia
    Aug
    Participated in "Economic Cooperation and industry development" projects organized by the Ministry of Trade, Industry and Energy
    May
    Participated in the 2015 Korea Trade Mission to India
    April
    Relocated to #305, Research Center 2 and expansion laboratory
    Feb
    Technology transfer EuDx™-MTB to NanoBioSis
  • 2014
    Nov
    Acquired certificate of ISO13485:2003
    Jun
    Acquired approval for EuDxTM-MTB detection kit from the MFDS (Ministry of Food & Drug Safety) and KGMP
    May
    Success in SMEs (The Promotion of Small And Medium Enterprises) “R&D Program for Establishment and Growth”
    Jan
    Relocated to #506, Venture Research Center,OSONG Medical Innovation Foundation
  • 2013
    Oct
    Acquired certificate of company affiliated research institute
    Oct
    Concluded strategic business partnership (R&D, Marketing) with Meta Biomed Co., Ltd.
    July
    Approved ‘Medical Device Manufacturing License’ (MFDS)
    April
    Acquired certificate of venture business (Korea Technology Finance Corporation)
    Feb
    Applied registration for domestic trademark of EuDxTM-MTB
  • 2012
    Nov
    Acquired patent implementation right for TB Real-time PCR
    Sep
    Founded EuDiPia Co., Ltd.
    Aug
    Moved into business center at Sogang University

TOP

Privacy Policy
Copyright"EUDIPIA Inc.". All Rights Reserved.